Topic: pharma CEO

With Gilead’s CEO on the way out and revenues tumbling, the company needs a leader who can pump up cancer sales. And it may have found just that.

What does it take for a company to attract millennials? An inspiring culture—and jeans, according to Novartis CEO Vas Narasimhan.

Takeda CEO Christophe Weber and Nissan's now-fallen chairman Carlos Ghosn have much more in common than their French nationality.

FSD Pharma taps competing prescription CBD company GW Pharma’s former top marketing executive to serve as its new CEO.

Pascal Soriot’s reign at AstraZeneca is once again rumored to be coming to an end, and the company has reportedly begun looking for his successor.

There's been no shortage of drug pricing talk in recent weeks, and now Merck's and Pfizer's CEOs have had a chance to voice their thoughts.

Perrigo CEO Uwe Roehrhoff is stepping down effective immediately, the company announced, to be replaced by former tobacco executive Murray Kessler.

Hours after Pfizer unveiled its CEO succession plan, industry watchers had one key question: Will incoming chief Albert Bourla chase M&A?

After steering Pfizer through nine years of selloffs, spinoffs, reorgs, drug launches, patent losses, dealmaking—and one big deal that didn’t—CEO Ian Read is stepping aside.

A policy change by the board of Merck & Co. will allow Ken Frazier to remain CEO after he turns 65 next year.